Document is current
Any future updates will be listed below
-
Authors
Yukishima, Toshitaka https://orcid.org/0000-0003-2265-6724
Kobayakawa, Tomonori https://orcid.org/0009-0002-6814-9920
Hirano, Yuji https://orcid.org/0000-0002-0422-8139
Kanayama, Yasuhide
Niimi, Rui https://orcid.org/0000-0002-2001-0674
Etani, Yuki https://orcid.org/0000-0001-5741-5969
Noguchi, Takaaki https://orcid.org/0000-0001-9938-6780
Noguchi, Taiji https://orcid.org/0000-0001-9165-5501
Shimoyama, Kumiko https://orcid.org/0009-0003-3496-3956
Maekawa, Yuichiro https://orcid.org/0000-0002-6792-8458
Ojima, Toshiyuki https://orcid.org/0000-0001-6888-0698
Nakata, Ken https://orcid.org/0000-0002-4086-4984
Okada, Seiji https://orcid.org/0000-0002-5107-8209
Ebina, Kosuke https://orcid.org/0000-0002-2426-1024
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Science Research from the Japanese Osteoporosis Society
The University of Osaka
- License Information
-
More Information
Article History
Received: 19 February 2026
Accepted: 21 April 2026
First Online: 8 May 2026
Declarations
Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Disclosure: KE has received research grants from Asahi-Kasei and Teijin Pharma. KE has received payments for lectures from AbbVie, Amgen, Asahi-Kasei, Astellas, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Gilead, Ono, Pfizer, Taisho, Tanabe-Mitsubishi, and Teijin Pharma. KE holds an additional post of the Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, supported by Asahi-Kasei. TK has received payments for lectures from Amgen, Asahi-Kasei, Daiichi Sankyo, Eli Lilly, and Teijin Pharma. YH has received payments for lectures from AbbVie, Amgen, Asahi-Kasei, Astellas, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Taisho, Tanabe-Mitsubishi, and Teijin Pharma. YK has received payments for lectures from AbbVie, Amgen, Asahi-Kasei, Astellas, Daiichi Sankyo, Eisai, Eli Lilly, Gilead and Taisho. RN has received payments for lectures from Amgen, Asahi-Kasei, Astellas, and Teijin Pharma. YE has received research grants and/or speaker fees from Asahi-Kasei, Eisai, Eli Lilly, Mitsubishi Tanabe, Ono Pharma, and Taisho. YE is affiliated with the Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, supported by Asahi-Kasei. KN supervises the Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, supported by Asahi-Kasei. TY, TN, TN, KS, YM, TO and SO declare that they have no conflicts of interest.
